Search

for
Search:

Research

5 / 1000+ results

research Liposomes and Niosomes as Topical Drug Delivery Systems

205 citations , January 2005 in “Skin pharmacology and physiology”

This review discusses how liposomes and niosomes can enhance drug penetration in topical delivery systems and emphasizes the importance of their specific composition, size, and type, but it reports no new results.

research Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: A review

202 citations , June 2005 in “Aaps Pharmscitech”

This review discusses the potential of lecithin organogels for improving topical drug delivery and presents no new experimental results; the authors highlight their stability and low skin irritancy as advantages.

Niosomes as a Promising Carrier for Topical Drug Delivery

research Niosomes as a propitious carrier for topical drug delivery

72 citations , December 2012 in “Expert Opinion on Drug Delivery”

This review discusses niosomes' increasing popularity in dermatology for topical drug delivery due to their ability to enhance drug penetration, provide sustained release, and carry various drugs, while reporting no new clinical findings.

research Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery

51 citations , October 2024 in “Pharmaceutics”

This review highlights the potential of permeation enhancers to improve the delivery of active ingredients across the skin, optimizing therapeutic outcomes despite challenges posed by individual variability and environmental factors, according to the authors' analysis of current understanding and applications in skincare and transdermal therapies.

research Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing

48 citations , January 2024 in “Frontiers in Pharmacology”

This paper reviews strategies to enhance the effectiveness of topical drug delivery by addressing skin barrier challenges, optimizing drug delivery systems, and personalizing treatment approaches, highlighting both current advancements and limitations in the field.

View more "topical drug" in research →

Community Join

5 / 1000+ results

community Haircafe - TOPICAL minoxidil is an anti aging drug

in Minoxidil 245 upvotes 1 year ago

Topical minoxidil may cause skin aging effects like wrinkles and dark circles, possibly due to its alcohol content, while oral finasteride is reported to make users look younger. Switching to oral minoxidil or using moisturizers might help reduce these skin issues.

community PSA: Besides topical minoxidil, its really rare for hair loss drugs to be fake

in Chat 9 upvotes 1 month ago

Oral finasteride, minoxidil, and dutasteride are unlikely to be fake, especially in tablet or capsule form, while topical minoxidil is often faked and should be purchased from reputable sources. Concerns about minoxidil affecting libido or causing erectile dysfunction are likely unfounded.

community Even if the new drugs succeed, how are we gonna apply so many topicals?

11 upvotes 4 months ago

New hair loss treatments like GT20029, Clascoterone, and PP405 are being discussed, with concerns about how to apply multiple topicals alongside existing treatments like minoxidil and finasteride. Suggestions include creating a routine, mixing treatments, or minimizing redundancy in treatment stacks.

community A concern regarding the upcoming androgen degrader drug GT20029

11 upvotes 1 year ago

GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.

community Why liposomal finasteride and minoxidil may be better than traditional topical solutions.

in Research/Science 2 upvotes 1 year ago

Liposomal formulations of finasteride and minoxidil may enhance drug delivery to the skin and hair follicles more effectively than traditional solutions, potentially improving treatment outcomes. However, more human clinical trials are needed to confirm these benefits.

View more "topical drug" in community →

Learn

9 / 801 results

learn Verteporfin

Is Verteporfin used as a topical treatment, injection, or oral medication for hair loss? Verteporfin is an intravenous drug approved only for an eye condition; it is not approved for hair loss in any form. In the few published hair reports it was injected into the scalp alongside surgical wounding — unverified case reports of one and two patients, not trial evidence.

learn Valproic acid

How is valproic acid being explored differently in topical hair products compared to its traditional oral medical use? Topical valproic acid is being studied for local effects on the hair follicle rather than the whole-body effects of the oral drug. The human evidence is one small randomized 24-week trial of an 8.3% spray; no topical valproate product is approved for hair loss.

learn Finasteride

Are there really risks with topical finasteride? Reports on topical finasteride describe scalp irritation and dermatitis as the effects specific to it, and blood levels lower than the oral drug; whether systemic side effects are genuinely rarer has not been measured in a trial powered to answer it. Both forms are prescription-only and contraindicated around pregnancy.

learn Spironolactone

How does spironolactone help reduce hair loss when used in topical or oral treatments? Studies report that spironolactone slows androgen-driven follicle miniaturisation by blocking androgen receptors, with most evidence in women and mostly alongside minoxidil; it is a prescription drug and its use for hair loss is off-label.

learn Metformin

diabetes drug with anti-inflammatory, immunomodulatory, and insulin-sensitizing properties

learn Minoxidil

An essential vasodilator with some anti-androgenic effects

From hypertension to hair: the unexpected story of minoxidil Minoxidil was developed as an oral blood-pressure drug and approved as Loniten in 1979; unwanted hair growth in patients led to topical Rogaine, approved for men in 1988 and for women in 1991. Trials support topical minoxidil for pattern hair loss, while low-dose oral minoxidil is a prescription drug used off-label and needs medical supervision.

learn Latanoprost

glaucoma medication with hair follicle stimulant effects

learn Vascular Endothelial Growth Factor

learn Overview

View more "topical drug" in learn →

Clinics

3 / 26 results

Experts

— no results

Try a deeper search in experts →